Cornelia A. Verberkt

Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status

Cornelia A. Verberkt, M.H.J. van den Beuken-van Everdingen, Jos M. G. A. Schols et al. · JAMA Internal Medicine · 2020 · 126 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study

Cornelia A. Verberkt, M.H.J. van den Beuken-van Everdingen, Frits M.E. Franssen et al. · Contemporary Clinical Trials · 2016 · 15 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Healthcare and Societal Costs in Patients with COPD and Breathlessness after Completion of a Comprehensive Rehabilitation Program

Cornelia A. Verberkt, M.H.J. van den Beuken-van Everdingen, Carmen D. Dirksen et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2021 · 13 citations · Full text

Medicine, Clinical Sciences, Rehabilitation Medicine +17

Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial

Cornelia A. Verberkt, M.H.J. van den Beuken-van Everdingen, Carmen D. Dirksen et al. · Respiratory Medicine · 2021 · 10 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +11

Morphine for chronic breathlessness in COPD: improvement predictors-cross-sectional study

Cornelia A. Verberkt, Marieke H J van den Beuken-Everdingen, Jos M. G. A. Schols et al. · BMJ Supportive & Palliative Care · 2022 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17